A 2024 double-blind randomized trial of 156 participants with early Parkinsons disease found that participants receiving a GLP-1 drug, lixisenatide, showed no progression of motor symptoms, compared to a measurable worsening on standard motor scales in the placebo group
Supply issues and spotty insurance coverage have driven some patients to seek out compounded versions of the drug, which tend to be less expensive (Amanda Andrade-Rhoades/The Associated Press)
However, evidence suggests that maintaining weight loss without pharmacological support remains challenging for most people due to biological adaptations that defend against weight loss
The Dangers of TikToks Gray-Market Melanotan Trend Despite all of that history, vials of Melanotan I and Melanotan II continue to circulate on gray-market websites
Equally, the ability to manage notificationspromotions, tournament alerts, or account remindershelps players stay informed without feeling overwhelmed
Additional research is now exploring combining retatrutide with other medications to determine if they can further enhance weight loss or glucose management
